MetaCap

Adicet Bio Insider Trades

NASDAQ: ACETHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.14-0.32 (-13.01%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
3 · $1.60M
Sales
4 · $674.85K
Shares bought / sold
223.60K / 104.66K
Net activity
Net buying $929,087

Adicet Bio insider activity

Over the last 12 months, Adicet Bio insiders reported 12 transactions on SEC Form 4: 3 open-market purchases and 4 sales. Insiders bought $1.6 million and sold $674,847 worth of stock, for net insider buying of $929,087. The largest seller was ORBIMED ADVISORS LLC & OrbiMed Capital GP V LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLC & OrbiMed Advisors Israel II Ltd & OrbiMed Israel GP II, L.P. & OrbiMed Israel GP Ltd. & OrbiMed Israel BioFund GP Limited Partnership, with $674,847 in reported sales.

The most recent filing shows RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & Kolchinsky Peter & Shah Rajeev M. (10% Owner) reporting a transaction in 250,000 shares on Apr 27, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ACET's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

ACET insider transactions

Adicet Bio insider transactions
DateInsiderTypeSharesValueFiling
Apr 27, 2026RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & Kolchinsky Peter & Shah Rajeev M.10% Ownerother250,000—Form 4
Apr 8, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP V LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLC & OrbiMed Advisors Israel II Ltd & OrbiMed Israel GP II, L.P. & OrbiMed Israel GP Ltd. & OrbiMed Israel BioFund GP Limited Partnership10% OwnerSale40,416$263.51KForm 4
Apr 8, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP V LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLC & OrbiMed Advisors Israel II Ltd & OrbiMed Israel GP II, L.P. & OrbiMed Israel GP Ltd. & OrbiMed Israel BioFund GP Limited Partnership10% OwnerSale32,523$204.57KForm 4
Apr 7, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP V LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLC & OrbiMed Advisors Israel II Ltd & OrbiMed Israel GP II, L.P. & OrbiMed Israel GP Ltd. & OrbiMed Israel BioFund GP Limited Partnership10% OwnerSale2,400$15.31KForm 4
Apr 7, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP V LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLC & OrbiMed Advisors Israel II Ltd & OrbiMed Israel GP II, L.P. & OrbiMed Israel GP Ltd. & OrbiMed Israel BioFund GP Limited Partnership10% OwnerSale29,319$191.45KForm 4
Feb 20, 2026RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & Kolchinsky Peter & Shah Rajeev M.10% OwnerBuy74,751$543.44KForm 4
Feb 19, 2026RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & Kolchinsky Peter & Shah Rajeev M.10% OwnerBuy74,268$535.47KForm 4
Feb 18, 2026RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & Kolchinsky Peter & Shah Rajeev M.10% OwnerBuy74,577$525.02KForm 4
Jan 24, 2026Schor ChenPresident & CEOTax withholding1,755$14.81KForm 4
Jan 24, 2026Healey DonChief Technology OfficerTax withholding535$4.52KForm 4
Jan 24, 2026Harvey Brian NicholasChief Financial OfficerTax withholding546$4.61KForm 4
Jan 24, 2026Aftab BlakeChief Scientific OfficerTax withholding535$4.52KForm 4
Oct 8, 2025ORBIMED ADVISORS LLC & OrbiMed Capital GP V LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLC & OrbiMed Advisors Israel II Ltd & OrbiMed Israel GP II, L.P. & OrbiMed Israel GP Ltd. & OrbiMed Israel BioFund GP Limited Partnership10% OwnerBuy3,500,000$3.50MForm 4
Oct 8, 2025ORBIMED ADVISORS LLC & OrbiMed Capital GP V LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLC & OrbiMed Advisors Israel II Ltd & OrbiMed Israel GP II, L.P. & OrbiMed Israel GP Ltd. & OrbiMed Israel BioFund GP Limited Partnership10% OwnerBuy1,500,000$1.50MForm 4
Jun 11, 2025Sinclair AndrewDirectorAward5,900—Form 4
Jun 11, 2025Peng KatieDirectorAward5,900—Form 4
Jun 11, 2025DUBIN STEVEDirectorAward5,900—Form 4
Jun 11, 2025Chodakewitz JeffreyDirectorAward5,900—Form 4
Jun 11, 2025Klickstein LloydDirectorAward5,900—Form 4
Jan 24, 2025Aftab BlakeChief Scientific OfficerTax withholding6,270$5.78KForm 4
Jan 24, 2025Schor ChenPresident & CEOTax withholding28,101$25.90KForm 4
Jan 24, 2025Harvey Brian NicholasChief Financial OfficerTax withholding8,752$8.07KForm 4
Jan 24, 2025Healey DonChief Technology OfficerTax withholding8,560$7.89KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related